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Abstract: A gene delivery concept based on ethylenediamine-functionalized single-walled 
carbon nanotubes (f-SWCNTs) using the oncogene suppressor p53 gene as a model gene was 
successfully tested in vitro in MCF-7 breast cancer cells. The f-SWCNTs-p53 complexes were 
introduced into the cell medium at a concentration of 20 µg mL−1 and cells were exposed for 
24, 48, and 72 hours. Standard ethidium bromide and acridine orange assays were used to 
detect apoptotic cells and indicated that a significantly larger percentage of the cells (approx 
40%) were dead after 72 hours of exposure to f-SWCNTs-p53 as compared to the control cells, 
which were exposed to only p53 or f-SWCNTs, respectively. To further support the uptake and 
expression of the genes within the cells, green fluorescent protein-tagged p53, attached to the 
f-SWCNTs was added to the medium and the complex was observed to be strongly expressed in 
the cells. Moreover, caspase 3 activity was found to be highly enhanced in cells incubated with 
the f-SWCNTs-p53 complex, indicating strongly induced apoptosis. This system could be the 
foundation for novel gene delivery platforms based on the unique structural and morphological 
properties of multi-functional nanomaterials.
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Introduction
Nanomaterials, with their unique dimensional and structural properties, have been used 
in a number of nanomedicine-related applications ranging from cancer targeting,1–3 
destruction,4–6 and visualization7 to tissue engineering and regeneration.8,9 In particular, 
carbon nanotubes with their 1D structures were reported to interact strongly with various 
biological systems10 and increase the activity of various drugs used in cancer treatment.11 
More recently, functionalized single-walled nanotubes (f-SWCNTs) have become one 
of the most frequently used nanodelivery vehicles and there is great interest in the use 
of these particles for multiple applications including diagnostics and drug delivery, as 
well as protein and gene delivery.2,6,10,12–15 The generation of f-  SWCNT-DNA complexes 
has been especially beneficial in two ways: 1) the presence of DNA in this complex 
highly stabilizes the carbon nanoparticle in aqueous suspensions and 2) the DNA mol-
ecule is protected from unwanted enzymatic cleavage and nucleic acid binding protein 
interference when attached to the carbon nanotubes.15–17 Another major advantage of 
using carbon nanotube-based materials as gene vectors is that they do not activate the 
naive primary B lymphocytes and are thus nontoxic.18International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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One of the genes most frequently delivered to cancer 
cells is the tumor suppressor protein, p53, which in humans 
is encoded by the TP53 gene.19–21 Protein 53 plays a role in 
apoptosis, genetic stability, and inhibition of angiogenesis.13 
Normal cells contain two copies of functional p53 gene, 
and the protein produced by this gene is activated either to 
coordinate the DNA repair process or induce cell suicide if 
DNA damage proves to be irreparable.19,20,22 Protein 53 can 
be activated in response to numerous stressors such as DNA 
damage, oxidative stress, osmotic shock, ribonucleotide 
depletion, or deregulated oncogene expression.23 When the 
normal protective function of p53 is lost, the cells lose their 
potential to control growth, which results in rapid growth 
and a progression toward malignancy.22 In many types of 
cancers, the loss of p53 activity may also result in resistance 
to radiotherapy and anticancer drugs.24
Protein 53 genes are frequently delivered together 
with various chemotherapeutic agents, which dramatically 
increases the efficacy of those drugs.24,25 Several in vitro 
studies clearly suggest that delivery of this tumor suppressor, 
especially in synergistic combination with cancer drugs, is 
an efficient mode of cancer treatment.26 Although numerous 
papers have emerged on the use of p53 as a model gene for 
testing various methods of gene delivery, such as targeted 
liposomes27,28 or polypeptide delivery vehicles,29 to cancer 
cells, the use of f-SWCNTs has not been reported.
In this work, we have examined the possibility of deliver-
ing f-SWNT-DNA complexes containing p53 into MCF-7 
breast cancer cells. The major goal of these studies has been 
to develop protocols for efficient DNA binding and delivery 
into cancer cells by using the well-characterized p53 gene 
as a model for cancer cell destruction. These studies have 
resulted in the successful generation of f-SWCNTs with 
circular plasmid DNA attached to the outer surface, which, 
when introduced in vitro to cancer cell cultures, were found 
to induce apoptosis in a significantly larger percentage of the 
cells as compared to the nanotubes without plasmid DNA 
attached to their outside surface. The methods presented here 
can now be applied as delivery platforms for other genes of 
interest for various biomedical applications. Using these 
particles as a foundation, further studies can be developed 
to generate more advanced particles that can be used for 
targeting molecules other than genes and/or powerful anti-
cancer drugs.
Materials and methods
Unless otherwise mentioned, all chemicals were purchased 
from Sigma-Aldrich (St Louis, MO). The human breast 
cancer cell line MCF-7 and Dulbecco’s Modified Eagle 
Medium were obtained from American Type Cell Culture 
(Manassas, VA). The p53 plasmids were purchased from 
Addgene (Cambridge, MA). The caspase assay kit was 
  purchased from BioVision Inc (Mountain View, CA), and 
the Gentamucin Reagent Solution was from MP Biomedicals, 
LLC (Illkirch, France).
carbon nanotube synthesis
Single-walled carbon nanotubes were synthesized on a 
bimetallic Fe-Co/MgO (2.5:2.5:95 wt%) catalyst   system, 
which was prepared as described previously.30 After a 
  thorough overnight drying, the catalyst system was   calcinated 
at 500°C for a few hours and about 50 mg of the catalyst 
was placed on a graphite susceptor, which was inserted 
into a quartz tube. A radio frequency (RF) generator with 
a   frequency of 350 kHz was used in the synthesis of the 
  carbon nanotubes. Argon (Ar) was first introduced at 
150 mL/minute into the quartz tube positioned inside the 
RF coil. After 10 minutes, the RF generator was turned on. 
Once the temperature of the graphite susceptor reached 
800°C,   methane was added at 40 mL/minute for 30 minutes. 
The carbon source and the RF generator were turned off and 
the sample was cooled to room temperature under Ar. The 
produced SWCNTs were mixed into a diluted HCl (1:1) solu-
tion and the mixture was stirred continuously for 24 hours. 
The SWCNT mixture was washed with deionized water to a 
pH of 7 and dried overnight at 100°C. The purified SWCNTs 
were oxidized at 430°C for 30 minutes to burn off amorphous 
carbon and to uncover the remaining catalyst nanoparticles. 
A second purification of SWCNTs was carried out with a 
nitric acid treatment to further remove any additional metal 
impurities. The final product contained SWCNTs function-
alized with carboxylic groups with enhanced dispersion 
properties in various solutions.
characterization techniques
A Mettler Toledo (Greifensee, Switzerland) TGA/SDTA 851e 
was used to carry out thermogravimetric analyses (TGA) 
with an airflow rate of 150 mL/minute. Approximately 
3 mg of the sample was heated from 25 to 850°C at a rate 
of 5°C/minute. Transmission electron microscopy (TEM) 
images were collected on a field emission JEM-2100F TEM 
(JEOL Inc, Tokyo, Japan) equipped with a CCD camera 
and an acceleration voltage of 100 kV . For TEM analysis, 
SWCNTs were homogeneously dispersed in 2-propanol by 
ultrasonication for 30 minutes. A few drops of the suspension 
were deposited on the TEM grid and allowed to air-dry International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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before analysis. A JEOL 7000F high-resolution scanning 
electron microscope was utilized to obtain scanning electron 
microscopy (SEM) images of the purified powdered samples. 
Before microscopy, the samples were mounted on aluminum 
pins with double-sided carbon tape.
The optical absorption spectra at UV-Vis-NIR range 
were recorded using a Shimadzu (Kyoto, Japan) UV-3600 
double beam spectrophotometer with three detectors. For 
the optical measurements, SWCNTs were individually 
  dispersed in an aqueous sodium cholate solution. To obtain 
a homogeneous solution, the mixture was first sonicated for 
1 hour and then centrifuged for 2 hours at 15000 × g using 
a high speed   centrifuge and the supernatant was utilized 
for optical analysis. Raman spectra of the SWCNTs were 
collected using a Horiba Jobin Yvon (Kyoto, Japan) Model 
LabRam HR800 system with a He-Ne laser (633 nm) as an 
excitation source. The Raman shifts were calibrated with a 
silicon wafer at a peak of 521 cm−1.
synthesis of amine-functionalized 
sWcNTs (f-sWcNTs)
In a 100 mL round-bottomed flask SWCNTs (50 mg), 
  dichloromethane (50 mL), and m-chloroperoxybenzoic acid 
(1 g) were mixed and the solution was refluxed for 48 hours. 
The solution was then filtered to collect the epoxidized 
SWCNTs and washed with dichloromethane (2 × 10 mL) and 
ethanol (2 × 10 mL). The epoxide-functionalized SWCNTs 
were mixed with lithium chloride (200 mg) and freshly 
distilled ethylenediamine (20 mL) and the mixture was 
refluxed for 18 hours under an inert atmosphere. After reflux, 
the reaction mixture was cooled and filtered to collect the 
product, which was then washed several times with ethanol 
(3 × 25 mL) to remove any excess ethylenediamine and 
lithium chloride. The resulting ethylenediamine f-SWCNTs 
were used for functionalization with the p53 genes.
Functionalization of f-sWcNT  
with p53 plasmid
Protein 53 plasmids (20 µg mL−1) were added to a suspension 
of f-SWCNTs in Dulbecco’s Modified Eagle Medium 
(DMEM) medium at a ratio (p53 plasmid:f-SWCNTs) of 
1:7.4 (w/w). The solution was mixed thoroughly using a 
pipette to develop the complex of p53 and f-SWCNTs.
cell culture
Human breast cancer cells (MCF-7) were grown in a 75 cm2 
culture flask with DMEM, supplemented with 10% calf 
serum, 100 U mL−1 penicillin, 100 U mL−1 streptomycin, 
and 50 µg mL−1 gentamicin sulfate and incubated in a 5% 
CO2 atmosphere at 37°C. The cells were subcultured by 
trypsinization and maintained in aseptic conditions with 
medium changes every 2–3 days.
cell treatment protocol
The cells were seeded at a density of 25 × 104 cells in each 
35 mm cell culture dish and grown for 72 hours in normal 
growth medium (as detailed above) until they reached 
60%–70% confluence. The medium was then removed and 
cells were supplied with medium containing 20 µg mL−1 
of F-SWCNTs, 20 µg mL−1–2.7 µg mL−1 F-SWCNTs-p53. 
A negative control was prepared by incubating the cells only 
with normal growth medium. The cells were harvested after 
24 hours, 48 hours, and 72 hours of incubation for further 
analysis. All experiments were carried out in triplicate.
cell assessment with light microscopy
The cells were plated for microscopy as described above 
and were washed three times with 10× phosphate buffered 
saline (PBS) and examined with an Olympus BX51 light 
microscope.
Analysis of cell death with ethidium 
bromide and acridine orange staining
To determine the degree of cell death, cells were harvested 
by trypsinization after an appropriate incubation period, were 
washed twice with 1× PBS buffer and stained with 17 µL 
of a solution containing 100 mg mL−1 acridine orange and 
100 mg mL−1 ethidium bromide in PBS. The harvested cells 
were placed on a slide and mounted with a cover slide. The 
stained cells were immediately visualized with UV light using 
an Olympus fluorescence microscope with a 10× objective 
equipped with a digital camera. Images were taken of random 
fields of view. The percentage of apoptosis was calculated 
by counting the number of live (green) and apoptotic (red) 
cells. Acridine orange stained the live cells, thus making 
them to appear green, whereas the apoptotic cells’ fragmented 
nuclear DNA was stained by ethidium bromide and appeared 
red when visualized under UV light using specific light 
filters. Each experiment was run in triplicate and the results 
expressed as mean ± standard deviation.
caspase assay
Caspase assays were performed to assess the level of 
apoptosis using the Biovision CaspGLOW Red Active 
  Caspase-3 staining kit. The cells were incubated   following the 
previously mentioned treatment protocol. After incubation, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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both the control and treated cells were trypsinized and the 
cells were resuspended in 1 mL of normal growth medium 
and incubated with 1 µL of Red-DEVD-FMK for 1 hour at 
37°C with 5% CO2 and then centrifuged for 5 minutes at 
3000 rpm. The cells were resuspended and washed twice with 
wash buffer and the final pellet was resuspended in 100 µL 
of the wash buffer. A few drops of the cell suspension were 
transferred to a microscope slide, which was examined with 
a light microscope. The brightness level, which indicates 
the level of caspase activation in the cells, was analyzed for 
each sample.
Green fluorescent protein expression
The cells were incubated under the standard conditions 
using plasmids with green fluorescence protein (GFP) 
tagged p53. After incubation, both the control and treated 
cells were harvested, washed twice with 1× PBS buffer, and 
  visualized under UV light by using an Olympus fluorescence 
microscope at 10× objective with an FTIC filter.
statistical studies
The data were analyzed by one-way ANOVA test and 
expressed as mean ± SD among three separate samples for 
each condition, the P-values of 0.05 or less were considered 
to indicate significance.
Results and discussion
synthesis and characterization  
of sWcNTs and f-sWcNTs and p53 
complexed f-sWcNTs
Our work explores the timely topic of nanodelivery of 
  anticancer genes into cancer cells. It is postulated that 
the internalization of f-SWCNTs-p53 complex and gene 
expression of p53 plasmid is a multi-step process   (Figure 1).15 
First, the f-SWCNTs-p53 complex enters into the cytoplasm 
via endocytosis and then moves to the nucleus. There, 
the f-SWCNTs-p53 plasmid complex is hypothesized to 
dissociate, as the amine groups become deprotonated due 
to an increase in the pH inside the nucleus. The p53 plasmid 
then undergoes transcription followed by transport of the 
transcripts to the cytoplasm where the p53 RNA is translated. 
This p53 protein then activates the apoptosis pathways in 
the cytoplasm.
To produce the detailed experimental data needed to 
more fully understand each of these steps, fiber-like, single-
walled carbon nanotubes (SWCNT) were synthesized and 
visualized by TEM (Inset in Figure 2C). Since impurities 
such as catalyst nanoparticles or carbonaceous by-products 
strongly affect the electrical, mechanical, and optical 
properties of the carbon nanotubes, high purity samples with 
Plasmid
DNA
CNT
CNT-DNA
complex
Endocytosis
Endosome
Unpacking
Endosome
escape
Cancer cell
Protein
translation
Nucleolus
DNA
transcription
Figure 1 schematic representation of f-sWcNT-p53 plasmid complex delivery into the cell and subsequent p53 gene expression.
Abbreviation: cNT, carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1049
p53 gene delivery using carbon nanotubes
optimal performance are necessary for various applications. 
  Thermogravimetric analysis is a useful technique for 
characterizing the purity of carbon nanotubes.31 The weight 
loss profile of the SWCNTs (after purification and removal of 
amorphous carbon) is shown in Figure 2A and indicates that 
the purity of the SWCNTs utilized in this work was about 
98.45%.   Scanning electron microscopy (SEM) was used to 
analyze the   morphology of the CNT products synthesized 
by RF catalytic chemical vapor deposition. Figure 2B and 
its inset show the SEM images of CNT bundles with an 
average length of several microns.
TEM and UV-Vis-NIR spectroscopy were utilized to 
analyze the diameter distribution of the SWCNTs. The 
inset in Figure 2C shows the TEM images of the SWCNTs 
with a diameter of 2 nm. The UV-Vis-NIR spectrum of the 
isolated SWCNTs (Figure 2C) shows a few absorbance 
peaks (between 600 to 1300 nm wavelengths) in the first 
van Hove optical transitions (S11) and the second van Hove 
transition peaks (S22), which correspond to the absorption of 
the isolated SWCNTs with small diameters. TEM and optical 
analysis indicated that the SWCNTs utilized in this manu-
script have diameters between 0.9 nm and 2.1 nm.32 Raman 
spectroscopic analyses were also performed on the purified 
SWCNTs to   further characterize their structural properties. 
The peaks present in the radial breathing mode (RBM) are 
often correlated with specific diameters of single-wall   carbon 
nanotubes.33 The Raman spectrum shown in Figure 2D indi-
cated the presence of SWCNTs with high crystallinity and 
with diameters between 0.7–1.7 nm. These values, which 
were calculated based on the RBM peaks positions present in 
the Raman spectra of the SWCNTs utilized in this work, are in 
good agreement with the optical and microscopy findings.
The purified SWCNTs were treated with chloroper-
benzoic acid to form epoxidized SWCNTs. This type of 
functional group was chosen because epoxides are highly 
reactive, allowing further functionalization with ethyl-
enediamine in the presence of lithium chloride to form 
amine f-SWCNTs. Due to the presence of free amine 
groups on the surface, f-SWCNTs remain protonated when 
exposed to cell culture medium. As a result, the negatively 
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Figure 2 A) TGA analysis of the SWCNTs after purification and removal of amorphous carbon; B) seM images of the sWcNT bundles synthesized on the bimetallic catalyst 
system, Inset; C) UV-Vis-NIr spectra of sWcNTs dispersed in aqueous solution. Inset: TeM images of the sWcNTs; D) Raman spectrum of the purified SWCNTs.
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charged plasmid containing p53 DNA is introduced to the 
positively-charged f-SWCNTs in the medium and the two 
components form a stable complex due to their strong ionic 
attractions. A   schematic representation of the sequence of 
the reaction and the steps involved in the production of the 
f-SWCNT-DNA complexes is shown in Figure 3A. Atomic 
force microscopy (AFM) images (Figure 3C and 3D) 
show that the f-SWCNTs are individually dispersed and 
successfully complexed with the p53 plasmids, which 
are visible on the sides of the nanotubes. The majority 
of f-SWCNTs were found to be bound with p53 plasmid 
when analyzed by AFM. It is also evident from the images 
that the plasmid DNA is not bound over the entire surface 
of the f-SWCNTs but rather is localized in specific areas 
along their length. Most likely, docking of p53 plasmids 
on the f-SWCNTs occurred with the highest density of 
protonated amine groups.
Incorporation f-sWcNT-p53 complexes 
into McF-7 cells: apoptosis assays  
and gFP expression
The uptake and internalization of the f-SWCNT-p53 
complexes is shown by optical microscopy in Figure 4A, 
which indicates that the f-SWCNTs-p53 complexes are 
found adhered both on the membrane and inside the cells. 
The agglomeration seen here also supports the hypothesis 
that the f-SWCNTs-p53 complexes are internalized by the 
cell, most probably via endocytosis.
In order to follow the events occurring after treatment of 
the cells with the f-SWCNTs-p53 complexes and to prove 
that the genes reach the nucleus of the cells, assays were 
also conducted with f-SWCNTs complexed with a plasmid 
coding for a p53-GFP fusion protein. Expression of the p53 
protein was visualized by tracking the expression of the 
GFP-tag (Figure 4B–D).35 Protein expression, as well as the 
NH3
NH3
NH3
NH3
NH
NH
NH
NH
A
i) mCPBA
ii) Ethylenediamine
Pipette up and
down 10 times (−ve)
Charged p53
plasmid
− −
−
−
−
B
C
5 nm
D
0 2.50
Flattern
5.00
0
2.50
5.00
µm
0 1.00 2.00
Flattern
0
2.00
1.00
µm
Figure 3 A) schematic representation of ethylenediamine functionalization of sWcNTs (f-sWcNTs) and formation of f-sWcNTs-p53 complex; B) TeM image of the 
sWcNTs used in this experiment; C and D) AFM images of f-sWcNTs-p53 complex formation. The presence of the p53 plasmids on the surface of the nanotubes can be 
clearly observed. In several cases, multiple p53 genes were found to be attached to a single nanotube.
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number of cells expressing GFP, was found to increase with 
increasing incubation time, with the maximum signal seen 
after 72 hours.
Figure 5 shows the result of incubation of cells with 
acridine orange and ethidium bromide to differentiate 
between viable and dead cells in the control and treatment 
groups.36 Figure 5 shows the effect on MCF-7 cells in cultures 
with different incubation times (24, 48, and 72 hours; 5A) and 
treatment with f-SWCNTs (Figure 5B, D–F), p53 plasmid 
(Figure 5B, G–I) and f-SWCNT-p53 (Figure 5B, J–L) and the 
control group (Figure 5B, A–C). After 72 hours incubation, 
the percentage of apoptotic cell death increased dramatically 
in cells treated with f-SWCNT-p53 and was significantly 
higher than that seen at other incubation times. The effect 
of f-SWCNT-p53 in cell death remains very similar to the 
control groups until 48 hours of incubation, suggesting that 
cell death was due to initiation of the apoptosis pathway 
by the expression of p53 and not by any toxic effect of the 
over-expression of the p53 protein itself.
One important fact is that, for the plasmid to be translo-
cated to the nucleus, it must be separated from the f-SWCNT. 
This is probably achieved by a change in the pH in the 
nucleus compared to the cytoplasmic pH which facilitates the 
separation of the p53 plasmids from f-SWCNTs.37 It should 
be noted that the percentage of dead cells in the f-SWCNT 
treated cells was slightly higher than in the   negative 
  control, due to the possible cytotoxic effects induced by the 
nanomaterials.38 The positive control group, where cells were 
incubated with 2.7 µg mL−1 of p53 plasmid under identical 
experimental conditions, shows results very similar to the 
negative control group indicating no induction of apoptosis 
and proving that cells were undergoing natural apoptosis 
instead of induced apoptosis. This also supported the fact that 
f-SWCNTs indeed acted as very efficient carriers for the plas-
mid and incorporated them into the cells. In contrast, the p53 
plasmids were unable to penetrate the cells when not attached 
to the f-SWCNTs, as no induced apoptosis was observed in 
this group. These data are also in very good agreement with 
GFP expression, which shows that the 72-hour incubation 
period provided adequate time for the plasmid to be expressed 
and activate the apoptotic pathways (Figure 4B–D).
caspase assay and elucidation  
of a possible caspase activation pathway
Caspase assays were conducted to further confirm enhanced 
apoptosis and provide important information regarding the 
possible mechanism of apoptosis induced by the wild type 
p53 plasmid delivered by f-SWCNT.39,40 The negative   control 
group showed negligible caspase activity (apoptosis) even 
after 72 hours (Figure 6, A–C) and the cells treated with 
f-  SWCNT showed similar results (Figure 6, D–F). The 
enhancement of the caspase signal after 72 hours was not 
  significant when compared to the f-SWCNT-p53 treated 
group (Figure 6, G–I) although it has a higher signal than 
the negative control group. This could be explained by 
possible cytotoxic effects of the f-SWCNT also evident in 
the ethidium bromide/acridine orange assays.
The caspases are a group of proteins belonging to the 
cysteine protease family that plays a key role in the apoptosis 
process. Primarily these proteins remain in an inactivated 
zymogen form that, upon induction of apoptosis, becomes 
activated. There are various pathways through which the 
caspase response occurs during apoptosis. The initiator 
  caspases are the first ones to be activated during apoptosis 
and are then involved in the activation of effector caspases. 
These effector caspases lead to the activation and cleavage 
of other caspases in the entire caspase cascade ultimately, 
leading to cell death by cleaving other cellular targets.
Based on our data, it is evident that the f-SWCNT-DNA 
complexes easily enter the cells and are translocated to the 
nucleus. This is followed by gene transcription and translation 
as is evident from the visualization of expressed GFP.
A
50 µm 500 µm 500 µm
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500 µm
Figure 4 A) Optical image showing uptake of f-sWcNT-p53 complex by McF-7 cells and agglomeration of f-sWcNT_p53 complex; B–D) expression of gFP tagged p53   
and f-sWcNT complex in McF-7 cells after 24, 48, and 72 hours of incubation with 20 µg mL−1 of f-sWcNTs and 2.7 µg mL−1 of gFP tagged p53 at 37°c and 5% cO2 
atmosphere. The arrows indicate the presence of nanotubes inside the cells.
Abbreviations: f-SWCNT, functionalized single-walled carbon nanotubes; GFP, green fluorescent protein.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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We have selected p53 as a model for our studies because 
it is one of the most significant genes in cancer proliferation. 
Identified in 1973, p53 was one of the first tumor   suppressor 
genes to be identified41 and is the most frequently mutated 
gene in many common human cancers, with mutations 
  estimated to occur in 50% of all cancers. The major   function 
of p53 is to repair cell damage or induce cell suicide, 
inhibiting the proliferation of abnormal cells and   preventing 
neoplastic development. In normal, unstressed cells, the level 
of p53 protein is downregulated by the binding of proteins 
that promote the degradation of p53 via the ubiquitin/ 
proteasome pathway. The majority of these proteins are also 
upregulated by p53 itself, which leads to a regulation loop 
that keeps p53 at very low levels in normal cells.   Therefore, 
the p53 signaling pathway is not active under normal cel-
lular conditions. Activation occurs in response to cellular 
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Figure 5 A) Percentage of dead McF-7 cells in both control and treatment after incubation with normal growth medium and medium containing 20 µg mL−1 f-sWcNTs and 
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the effect of F-sWcNTs delivered p53 on induction apoptosis by ethidium bromide/acridine orange assay in McF-7 cell line, where live cells are green and dead cells appear 
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stresses, such as DNA damage, oxidative stress, osmotic 
shock, ribonucleotide depletion, or deregulation of oncogene 
expression.23 In these stressed cells, negative regulators are 
inhibited, allowing expressed p53 protein to accumulate, 
leading to over-translation of p53 RNA, and thus, p53 pro-
tein accumulation. Finally, a series of modulators (kinases, 
acetylases) activate p53 transcriptional activity.
Recently, knowledge of the upstream pathways regu-
lating p53 activity has increased greatly and   numerous 
transcriptional targets for p53 have been described. These 
data support an important role for p53 in mammary 
carcinogenesis. In breast cancer, p53 mutation is associated 
with more aggressive disease and worse overall survival 
rates.39,40 New data have also emerged that have resulted in 
the elucidation of other molecular mechanisms, in addition 
to mutation, by which p53 is disabled in breast cancer and 
have provided new insights into pathways of neoplasia 
in this tissue. Genetic and epigenetic changes induced by 
regulators specific to the activity and transcriptional targets 
of the p53 gene in breast cancers were recently identified.42 
A thorough understanding of the molecular pathology 
  corresponding to the structure and expression of constituents 
of the p53 pathway is expected to have a major impact 
on the identification, precise diagnosis, and treatment of 
breast cancer. A number of innovative strategies have been 
proposed to restore p53 function to tumors.43 Our study is 
among the most recent and we anticipate that ours and other 
novel therapeutic approaches targeted to the p53 pathway 
will significantly impact the clinical outcome for patients 
with breast cancer.
At present, we can only speculate as to the mechanism for 
the induction apoptotic events after f-SWCNT-p53 treatment. 
One pathway that could be involved is the upregulation of the 
BAX protein by expressed p53, with the help of cytochrome-C, 
which eventually activates the pro-apoptosome complex. 
The complex activates caspase-9 that eventually activates 
caspase-3, leading to the degradation and fragmentation of 
the chromosomal DNA of the apoptotic cell.44,45 However, 
other mechanisms of caspase activation may contribute to 
the death of cells and should be taken into consideration.46,47 
The p53 gene over-expression upregulates the release and 
activation of one of the Bcl-2 procaspase family proteins. The 
BAX protein contributes to p53-dependent tumor suppression 
and apoptosis in vitro, allocated to the mitochondria, and 
eventually leads to the activation of cytochrome-C protein 
through the mitochondrial apoptosis pathway. The presence 
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Figure 6 caspase-3 activity in McF-7 cells. A–C) the caspase activity in control cells (without any treatment); D–F) caspase activity in McF-7 cells incubated with 20 µg mL−1 
f-sWcNTs; G–I) caspase activity in McF-7 cells incubated with 20 µg mL−1 of f-sWcNTs and 2.7 µg mL−1 p53 plasmid complex for 24, 48, and 72 hours, respectively. The 
caspase-3 assay was performed following the manufacturer’s instructions for the Biovision caspgLOW red Active caspase-3 staining kit; images were taken after exposing 
the cells under UV light with TRITC filter.
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of the procaspase-9 and the Apaf-1/ATP cofactors will play 
an important role in apoptosome complex formation and the 
cleavage of active caspase-9 into the cytoplasm that has the 
potential for caspase-3 activation leading to the degradation 
and fragmentation of the   chromosomal DNA of the apoptotic 
cell. Furthermore, our results demonstrate the potential of 
functionalized carbon nanotubes for increasing the induction 
of apoptosis by the p53 gene that will be implicated for 
  targeted apoptosis-inducing gene therapy.
Conclusions
In this work, we have demonstrated the ability of f-SWCNT-p53 
complexes to penetrate MCF-7 cells and facilitate the delivery 
of p53 plasmid DNA, resulting in the expression of this protein 
in these cells. The major purpose of this study was to optimize 
the methods for binding plasmid DNA to the f-SWCNTs, fol-
lowed by detailed characterization of these complexes as gene 
delivery vehicles. It should be emphasized that the technique 
described in this work is designed to be a tool for the preliminary 
screening of   different genes for their ability to affect cancer 
cell growth. At this time, the targeted delivery of the genes 
and the specific type of f-SWCNT used are not as important as 
their ability to deliver potential anticancer genes to these cells 
and assess their effects.   Experiments using f-SWCNT-DNA 
complexes for use in selective delivery of specific antibodies 
to breast cancer cells, as well as f-SWCNTs that are easily 
biodegradable and nontoxic, are in progress. These studies will 
allow the techniques to be moved to in vivo models.
Acknowledgments
Financial support from the Arkansas Science and Technology 
Authority (ASTA) grant nr 08-CAT-03, the US Army 
Telemedicine, and Advanced Technology Research Center 
is highly appreciated. AR-P was supported by the NIH-
GM075893 grant.
Disclosure
The authors declare no conflicts of interests in this work.
References
1.  Ou Z, Wu B, Xing D, Zhou F, Wang H, Tang Y. Functional single-walled 
carbon nanotubes based on an integrin αvβ3 monoclonal antibody 
for highly efficient cancer cell targeting. Nanotechnology. 2009;20: 
105102.
2.  Xiao Y, Gao X, Taratula O, et al. Anti-HER2 IgY antibody-functionalized 
single-walled carbon nanotubes for detection and selective destruction 
of breast cancer cells. BMC Cancer. 2009;9:351.
3.  Bhirde AA, Patel V , Gavard J, et al. Targeted killing of cancer cells in vivo 
and in vitro with EGF-directed carbon nanotube-based drug delivery. 
ACS Nano. 2009;3:307–316.
  4.  Panchapakesan B, Lu S, Sivakumar K, Teker K, Cesarone G, 
Wickstrom E. Single-wall carbon nanotube nanobomb agents for killing 
breast cancer cells. Nano Biotechnology. 2005;1:133–140.
  5.  Kam NWS, Connell OM, Wisdom AJ, Dai H. Carbon nanotubes 
as   multifunctional biological transporters and near-infrared agents 
for selective cancer cell destruction. Proc Natl Acad Sci. 2005;102: 
11600–11605.
  6.  Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ. Targeted single-wall 
carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a 
homing device. J Am Chem Soc. 2008;130:11467–11476.
  7.  Malhotra R, Patel V , Vaque JP, Gutkind JS, Rusling JF. Ultrasensitive 
electrochemical immunosensor for oral cancer biomarker IL-6 using 
carbon nanotube forest electrodes and multilabel amplification. Anal 
Chem. 2010;82:3118–3123.
  8.  Shi X, Sitharaman B, Pham QP, et al. Fabrication of porous ultra-short 
single-walled carbon nanotube nanocomposite scaffolds for bone tissue 
engineering. Biomaterials. 2007;28:4078–4090.
  9.  MacDonald RA, Laurenzi BF, Viswanathan G, Ajayan PM, 
  Stegemann JP. Collagen-carbon nanotube composite materials as 
  scaffolds in tissue engineering. J Biomed Mater Res, Part A. 2005;74A: 
489–496.
  10.  Ladeira MS, Andrade VA, Gomes ERM, et al. Highly efficient siRNA 
delivery system into human and murine cells using single-wall carbon 
nanotubes. Nanotechnology. 2010;21:385101.
  11.  Mahmood M, Karmakar A, Fejleh A, et al. Synergistic enhancement of 
cancer therapy using a combination of carbon nanotubes and anti-tumor 
drug. Nanomedicine. 2009;4:883–893.
  12.  Kam NWS, Dai H. Carbon nanotubes as intracellular protein 
  transporters: generality and biological functionality. J Am Chem Soc. 
2005;127: 6021–6026.
  13.  Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems 
for cancer therapy. Adv Drug Delivery Rev. 2004;56:1649–1659.
  14.  Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat 
Rev Cancer. 2005;5:161–171.
  15.  Singh R, Pantarotto D, McCarthy D, et al. Binding and condensation 
of plasmid DNA onto functionalized carbon nanotubes: toward the 
construction of nanotube-based gene delivery vectors. J Am Chem Soc. 
2005;127:4388–4396.
  16.  Wu Y, Phillips JA, Liu H, Yang R, Tan W. Carbon nanotubes protect DNA 
strands during cellular delivery. ACS Nano. 2008;2:2023–2028.
  17.  Bell S, Klein C, Muller L, Hansen S, Buchner J. p53 contains 
large unstructured regions in its native state. J Mol Biol. 2002;322: 
917–927.
  18.  Cai D, Doughty CA, Potocky TB, et al. Carbon nanotube-mediated 
delivery of nucleic acids does not result in non-specific activation of 
B lymphocytes. Nanotechnology. 2007;18:365101.
  19.  Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S. 
Isolation and characterization of a human p53 cDNA clone: expression 
of the human p53 gene. EMBO J. 1984;3:3257–3262.
  20.  Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of 
gene for human p53 tumor antigen to band 17p13. Nature. 1986;320: 
84–85.
  21.  Kern SE, Kinzler KW, Bruskin A, et al. Identification of p53 as a   
sequence-specific DNA-binding protein. Science. 1991;252: 
1708–1711.
  22.  Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in 
the development of human papillomavirus-associated cancer. Nature. 
1998;393:229–234.
  23.  Han E-S, Muller FL, Perez VI, et al. The in vivo gene expression 
signature of oxidative stress. Physiol Genomics. 2008;34:112–126.
  24.  Li YX, Lin ZB, Tan HR. Wild type p53 increased chemosensitivity of 
drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells. 
Acta Pharmacol Sin. 2004;25:76–82.
  25.  Xu L, Tang W-H, Huang C-C, et al. Systemic p53 gene therapy of cancer 
with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol 
Med. 2001;7:723–734.International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
1055
p53 gene delivery using carbon nanotubes
  26.  Gunther M, Wagner E, Ogris M. Specific targets in tumor tissue for 
the delivery of therapeutic genes. Curr Med Chem Anticancer Agents. 
2005;5:157–171.
  27.  Sapra P, Tyagi P, Allen TM. Ligand-targeted liposomes for cancer 
treatment. Curr Drug Delivery. 2005;2:369–381.
  28.  Ledley FD. Nonviral gene therapy: the promise of genes as 
pharmaceutical products. Hum Gene Ther. 1995;6:1129–1144.
  29.  Mae M, Langel U. Cell-penetrating peptides as vectors for peptide, 
protein and oligonucleotide delivery. Curr Opin Pharmacol. 2006;6: 
509–514.
  30.  Dervishi E, Li Z, Xu Y, et al. The influence of Fe-Co/MgO catalyst 
composition on the growth properties of carbon nanotubes. Part Sci 
Technol. 2009;27:222–237.
  31.  Arepalli S, Nikolaev P, Gorelik O, et al. Protocol for the characterization 
of single-wall carbon nanotubes material quality. Carbon. 2004; 
42:1783.
  32.  Dervishi E, Li Z, Watanabe F, et al. Thermally controlled synthesis of 
single-wall carbon nanotubes with selective diameters. J Mater Chem. 
2009;19:3004–3012.
  33.  Dresselhaus MS, Dresselhaus G, Saito R, Jorio A. Raman spectroscopy 
of carbon nanotubes. Phys Rep. 2005;409:47–99.
  34.  Alkhalaf M, Mowafy E-AM. Overexpression of wild-type p53 gene 
renders MCF-7 breast cancer cells more sensitive to the antiproliferative 
effect of progesterone. J Endocrinol. 2003;179:55–62.
  35.  Soboleski MR, Oaks J, Halford WP. Green fluorescent protein is a 
quantitative reporter of gene expression in individual eukaryotic cells. 
FASEB J. 2005;19:440–442.
  36.  Babykutty S, Padikkala J, Sathiadevan PP, et al. Apoptosis induction 
of centella asiatica on human breast cancer cells. Afr J Trad Cam. 
2009;6:9–16.
  37.  Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in 
human breast tumor cells and implications for chemotherapy. J Exp 
Med. 1998;187:1583–1598.
  38.  Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and 
single-wall carbon nanotubes in neural phaeochromocytoma-derived 
PC12 cells. ACS Nano. 2010;4:3181–3186.
  39.  Aisha AFA, Alrokayan SA, Abu-Salah KM, Darwis Y, Majid 
Abdul AMS. In vitro cytotoxic and apoptotic properties of the stem 
bark extract of sandoricum koetjape on breast cancer cell. Int J Can 
Res. 2009;5:123–129.
  40.  Benjamin CW, Hiebsch RR, Jones DA. Caspase activation in 
MCF7 cells responding to etoposide treatment. Mol Pharmacol. 1998; 
53:446–450.
  41.  DeLeo AB, Jay G, Appella E, Dubois GC, Law LW, Old LJ. Detection 
of a transformation-related antigen in chemically induced sarcomas and 
other transformed cells of the mouse. Proc Natl Acad Sci U S A. 1979; 
76:2420–2424.
  42.  Gasco M, Shami S, Crook T. The p53 pathway in breast cancer. Breast 
Cancer Res. 2002;4:70–76.
  43.  Vogelstein B, Kinzler KW. Achilles’ heel of cancer? Nature. 2001;412: 
914–921.
  44.  Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. 
  Biochem Soc Trans. 2001;29:684–688.
  45.  Gomyo Y, Sasaki J-I, Branch C, Roth JA, Mukhopadhyay T. 
  5-aza-20-deoxycytidine upregulates caspase-9 expression cooperating 
with p53-induced apoptosis in human lung cancer cells. Oncogene. 
2004;23:6779–6787.
  46.  Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required 
for DNA fragmentation and morphological changes associated with 
apoptosis. J Biol Chem. 1998;273:9357–9360.
  47.  Steele JA, Prentice GA, Hoffbrand VA, et al. p53-mediated apoptosis 
of CLL cells: evidence for a transcription-independent mechanism. 
Blood. 2008;112:3827–3834.